Recerca > Càncer

Grup de recerca de biomarcadors en càncer (GReBiC)

Nombre de publicacions
495
Cercador de publicacions

  • Codony-Servat, J; Cuatrecasas, M; Asensio, E; Montironi, C; Martinez-Cardus, A; Marin-Aguilera, M; Horndler, C; Martinez-Balibrea, E; Rubini, M; Jares, P; Reig, O; Victoria, I; Gaba, L; Martin-Richard, M; Alonso, V; Escudero, P; Fernandez-Martos, C; Feliu, J; Mendez, JC; Mendez, M; Gallego, J; Salud, A; Rojo, F; Castells, A; Prat, A; Rosell, R; Garcia-Albeniz, X; Camps, J; Maurel, J

    Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

    BRITISH JOURNAL OF CANCER 117 1777-1786. .

    [doi:10.1038/bjc.2017.279]

  • Porcel, JM; Sole, C; Salud, A; Bielsa, S

    Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion

    Lung 195 775-779. .

    [doi:10.1007/s00408-017-0050-1]

  • Civit, MC; Viles, D; Porcel, JM

    Hedinger syndrome

    REVISTA CLINICA ESPANOLA 217 489-490. .

    [doi:10.1016/j.rce.2017.03.009]

  • Fitzgerald, Deirdre B.; Leong, Sulyn; Budgeon, Charley A.; Murray, Kevin; Rosenstengel, Andrew; Smith, Nicola; Bielsa, Silvia; Clive, Amelia O.; Maskell, Nick; Porcel, Jose; Lee, Y. C. Gary

    RELATIONSHIP OF PLEURAL FLUID PH AND GLUCOSE: A MULTI-CENTRE STUDY OF 2971 CASES

    RESPIROLOGY 22 42-42. .

  • Ferreiro, L; Porcel, JM; Valdes, L

    Diagnosis and Management of Pleural Transudates

    ARCHIVOS DE BRONCONEUMOLOGIA 53 629-636. .

    [doi:10.1016/j.arbr.2017.09.004]

  • Vallez-Valero, L.; Rius-Perera, J.; Gilabert Sotoca, M.; Mangues-Bafalluy, I; Schoenenberger, J. A.; Salud-Salvia, M. A.

    USE OF ABIRATERONE AND ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT-PROSTATE CANCER IN ROUTINE CLINICAL PRACTICE

    VALUE IN HEALTH 20 417-417. .

    [doi:10.1016/j.jval.2017.08.114]

  • Porcel, JM

    The case against performing pleural biopsies for the aetiological diagnosis of exudates

    REVISTA CLINICA ESPANOLA 217 423-426. .

    [doi:10.1016/j.rce.2017.02.016]

  • Rugo, HS; Tredan, O; Ro, J; Morales, SM; Campone, M; Musolino, A; Afonso, N; Ferreira, M; Park, KH; Cortes, J; Tan, AR; Blum, JL; Eaton, L; Gause, CK; Wang, Z; Im, E; Mauro, DJ; Jones, MB; Denker, A; Baselga, J

    A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer

    BREAST CANCER RESEARCH AND TREATMENT 165 601-609. .

    [doi:10.1007/s10549-017-4375-5]

  • Salazar, R.; Azuara, D.; Vieitez, J. M.; Paez, D.; Santos, C.; Falco, E.; Elez, E.; Lopez Lopez, C.; Valladares-Ayerbes, M.; Robles, L.; Garcia-Alfonso, P.; Buges, C.; Ogaya, G. Duran; Salud Salvia, M. A.; Navarro, V.; Capella, G.; Aranda Aguilar, E.

    ULTRA clinical trial: Prospective comparative clinical outcome analysis of three different RAS/BRAF sensitivity mutational cut-offs. A Phase II study of the Spanish TTD Group

    ANNALS OF ONCOLOGY 28 -. .

  • Morales, S.; Gasol Cudos, A.; Novell Alvarez, A.; Vilardell Villellas, F.; Panades Siurana, M. J.; Canosa Morales, C.; Mele Olive, J.; Iglesias Martinez, E.

    Vitamin D as a prognostic factor in triple negative early breast cancer

    ANNALS OF ONCOLOGY 28 -. .

  • Villagrasa Gonzalez, P.; Prat, A.; Oliveira, M.; de la Pena, L.; Gonzalez, X.; Cortes Castan, J.; Rios, J.; Vazquez, J.; Martinez Janez, N.; Perello Martorell, A.; Garau, I.; Martinez de Duenas, E.; Morales, S.; Mele, M.; Bermejo De las Heras, B.; Ciruelos, E.

    SOLTI-1303 PATRICIA: A phase II study of palbociclib and trastuzumab (with or without letrozole in ER plus ) in previously trastuzumab-pretreated, postmenopausal patients with HER2-positive metastatic breast cancer

    ANNALS OF ONCOLOGY 28 -. .

  • von Minckwitz, G.; Ponomarova, O.; Morales, S.; Zhang, N.; Hanes, V.

    Efficacy and safety of biosimilar ABP 980 compared with trastuzumab in HER2 positive early breast cancer

    ANNALS OF ONCOLOGY 28 -. .